Bio

Antoine Pau is a senior partner at Truffle Capital. Antoine joined Truffle Capital in 2008 after experiences at Novartis Pharma (oncology business unit) and Mazars (audit and transaction services). His expertise and track record cover the creation, structuration and financing of healthcare companies from early R&D to commercial stage, IPO or trade sale. Antoine is a board member of Holistick Medical (transcatheter patch for PFO closure, licensed from Harvard University and MIT), BariaTek Medical (endoscopic bariatric surgery) as well as Skinosive (innovation in sun protection). He is currently the acting CEO of SpikImm, founded by Truffle Capital and the Institut Pasteur to develop mAbs to prevent COVID-19. Pharmacist and graduated from the ESSEC Business School (Master in Management), Antoine is a guest lecturer at Sorbonne University, ESSEC, as well as a regular jury member at X-HEC Entrepreneurs.